Updated:
Entellus Medical
Entellus Medical is a US-based company founded in 2006 in Plymouth. It develops minimally invasive balloon dilation technologies for sinusitis treatment.
Overview
Entellus Medical is a US-based company founded in 2006 in Plymouth. It develops minimally invasive balloon dilation technologies for sinusitis treatment. The company has secured $92 million in total funding.
General information
Location
Region
North America
Country
United States
City
Maple Grove
Corporate office
Maple Grove, MN, United States
Frequently asked questions
What products did Entellus Medical develop?
Entellus Medical developed the XprESS Multi-Sinus Dilation System, a balloon dilation device designed for minimally invasive treatment of chronic rhinosinusitis. The system allowed surgeons to dilate multiple sinus passageways with a single device, differentiating it from earlier balloon dilation products. It was FDA-cleared and marketed globally.
What happened to Entellus Medical after the acquisition?
After Stryker Corporation acquired Entellus Medical in 2016 for about $1.1 billion, the firm became part of Stryker’s Neurotechnology and ENT division. The XprESS system continues to be sold under Stryker’s brand. Entellus Medical no longer operates independently; its operations and team were integrated into Stryker.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: